Occurrence of male breast cancer, a rare disease, peaks at age 71 years. Familial cases
usually have BRCA2 rather than BRCA1 mutations. Occupational risks include high …

Background The causes, optimal treatments, and medical/psychosocial sequelae of breast
cancer in men are poorly understood. Design A systematic review of the English language …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Background Breast cancer is rare in men and managed by extrapolating from breast cancer
in women. The clinicopathological features of male breast cancer, however, differ from those …

Simple Summary Male breast cancer (MBC) is a rare disease. Genetic factors predispose to
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …

Male breast cancer (MBC), one of the rare types of cancer among men where the global
incidence rate is 1.8% of all breast cancers cases with a yearly increase in a pace of 1.1 …

Background The male breast cancer (MBC) is a rare and represents less than 1% of all
malignancies in men and only 1% of all breast cancers incident. We illustrate the experience …

Purpose Because of its rarity, there are no randomized trials investigating postmastectomy
radiation therapy (PMRT) in male breast cancer. This study retrospectively examines the …

Background Current treatment guidelines for male breast cancer are predominantly guided
by female-only clinical trials. With scarce research, it is unclear whether breast-conserving …

Objective: To review presentation, diagnosis, treatment and prognosis of male breast
cancer. Method: A systematic review of the English language literature between 1990 and …